Adherence to recommendations for cervical and breast cancer screening in systemic sclerosis.

The aim of the study was to evaluate the adherence of systemic sclerosis (SSc) female patients to cervix and breast cancer screening procedures, as suggested by local guidelines. A cohort of 84 SSc women was asked if they had undergone mammography and Pap test during the previous 2- and 3-year intervals, as indicated according to the Italian recommendations. The results were compared with those collected in patients affected by other chronic rheumatic disorders and in the general population. More than 85% of SSc women declared to comply with an age-related cervix and breast cancer screening schedule. The data were similar to those collected in patients affected by other chronic rheumatic disorders, whereas the subjects belonging to the general population reported to undergo breast cancer screening more frequently. Among SSc women, neither the educational level, nor the lung and skin involvement influenced their cancer screening program compliance. Only a positive history of ischemic digital ulcers seemed to interfere with mammography. Our study reported a very high percentage of SSc female patients who adhered to programs for the early detection of cervical and breast cancer. The significant adherence to guidelines may be due to the schedule adopted by the local health public service, which regularly invites eligible subjects by mail to undergo cancer screening at no charge.

[1]  Sindhu R. Johnson,et al.  The Effect of Male Sex on Survival in Systemic Sclerosis , 2014, The Journal of Rheumatology.

[2]  D. Isenberg,et al.  Cancer complicating systemic lupus erythematosus – a dichotomy emerging from a nested case-control study , 2013, Lupus.

[3]  D. Sugiyama,et al.  Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. , 2013, Arthritis and rheumatism.

[4]  C. Denton,et al.  Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. , 2013, Clinical and experimental rheumatology.

[5]  C. Gordon,et al.  Systemic lupus and malignancies , 2012, Current opinion in rheumatology.

[6]  M. Santiago,et al.  Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review , 2011, Clinical Rheumatology.

[7]  S. Bombardieri,et al.  [Adherence to cervical cancer screening in an Italian SLE cohort]. , 2011, Reumatismo.

[8]  L. Trupin,et al.  Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study , 2010, Arthritis research & therapy.

[9]  F. Wolfe,et al.  The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity , 2010, Arthritis care & research.

[10]  H. Nelson,et al.  Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[11]  M. Revel,et al.  Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis , 2009, Annals of the rheumatic diseases.

[12]  M. Hudson,et al.  Reports of abnormal cervical cancer screening tests in systemic sclerosis. , 2008, Rheumatology.

[13]  T. Johnson,et al.  Accuracy of Self-Reported Cancer-Screening Histories: A Meta-analysis , 2008, Cancer Epidemiology Biomarkers & Prevention.

[14]  C. Denton,et al.  Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis , 2007, Annals of the rheumatic diseases.

[15]  A. Gelber,et al.  Age and risk of pulmonary arterial hypertension in scleroderma. , 2003, Chest.

[16]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[17]  P. Babb,et al.  Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. , 1999, BMJ.

[18]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[19]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[20]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[21]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[22]  C. la Vecchia,et al.  Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. , 2013, Rheumatology.

[23]  L. Punzi,et al.  The social costs of digital ulcer management in sclerodema patients: an observational Italian pilot study. , 2010, Joint, bone, spine : revue du rhumatisme.

[24]  A. Anttila,et al.  Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. , 2007, Collegium antropologicum.

[25]  T. Batinac,et al.  Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions. , 2007, Collegium antropologicum.

[26]  C. Pineau,et al.  Cancer screening in patients with systemic lupus erythematosus. , 2006, The Journal of rheumatology.

[27]  J. Seibold,et al.  Assessment of skin, joint, tendon and muscle involvement. , 2003, Clinical and experimental rheumatology.

[28]  T. Medsger,et al.  Assessment of disease severity and prognosis. , 2003, Clinical and experimental rheumatology.